Skip to main navigation Skip to search Skip to main content

Converting p53 from a killer into a healer

Research output: Contribution to journal › Short survey › peer-review

43 Scopus citations

Abstract

Selenium-containing compounds are in phase 2 and 3 clinical trials for prostate cancer prevention, although it is unclear how they work. A study suggests that selenium can facilitate DNA repair by activating the p53 tumor suppressor in an unusual way.

Original languageEnglish
Pages (from-to)1196-1198
Number of pages3
JournalNature Medicine
Volume8
Issue number11
DOIs
StatePublished - Nov 1 2002

Fingerprint

Dive into the research topics of 'Converting p53 from a killer into a healer'. Together they form a unique fingerprint.

Cite this